Advanced search
Publication Cover
Hypoxia Volume 5, 2017 - Issue
Journal homepage
91
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer

Todd W SeeleyTherapeutics R&D, FibroGen, Inc., San Francisco, CA, USACorrespondence[email protected]
,
Mark D SternlichtTherapeutics R&D, FibroGen, Inc., San Francisco, CA, USA
,
Stephen J KlausTherapeutics R&D, FibroGen, Inc., San Francisco, CA, USA
,
Thomas B NeffTherapeutics R&D, FibroGen, Inc., San Francisco, CA, USA
&
David Y LiuTherapeutics R&D, FibroGen, Inc., San Francisco, CA, USA
Pages 1-9 | Published online: 10 Mar 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.